tiprankstipranks
Trending News
More News >
Gland Pharma Ltd. (IN:GLAND)
:GLAND
India Market

Gland Pharma Ltd. (GLAND) Financial Statements

Compare
0 Followers

Gland Pharma Ltd. Financial Overview

Gland Pharma Ltd.'s market cap is currently ₹308.73B. The company's EPS TTM is ₹11.3; its P/E ratio is 44.19; and it has a dividend yield of 1.07%. Gland Pharma Ltd. is scheduled to report earnings on May 20, 2025, and the estimated EPS forecast is ₹13.38. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 56.17B₹ 56.42B₹ 36.25B₹ 43.84B₹ 34.24B
Gross Profit₹ 33.27B₹ 30.88B₹ 19.39B₹ 22.75B₹ 19.32B
Operating Income₹ 17.33B₹ 16.45B₹ 8.84B₹ 14.00B₹ 12.03B
EBITDA₹ 12.69B₹ 15.03B₹ 12.09B₹ 17.34B₹ 14.37B
Net Income₹ 6.99B₹ 7.72B₹ 7.81B₹ 12.12B₹ 9.97B
Balance Sheet
Cash & Short-Term Investments₹ 30.50B₹ 19.39B₹ 38.36B₹ 32.43B₹ 24.47B
Total Assets₹ 112.25B₹ 106.61B₹ 87.78B₹ 78.34B₹ 64.96B
Total Debt₹ 3.14B₹ 3.72B₹ 44.53M₹ 47.43M₹ 49.95M
Net Debt₹ -22.42B₹ 150.78M₹ -19.04B₹ -3.11B₹ -4.87B
Total Liabilities₹ 20.74B₹ 19.37B₹ 8.19B₹ 6.76B₹ 5.93B
Stockholders' Equity₹ 91.51B₹ 87.24B₹ 79.59B₹ 71.58B₹ 59.03B
Cash Flow
Free Cash Flow₹ 5.30B₹ 5.99B₹ 1.41B₹ 2.69B₹ 3.76B
Operating Cash Flow₹ 9.15B₹ 9.97B₹ 3.64B₹ 7.91B₹ 6.05B
Investing Cash Flow₹ 17.05B₹ -17.57B₹ 12.08B₹ -10.03B₹ -15.24B
Financing Cash Flow₹ -4.33B₹ -7.99B₹ 149.19M₹ 348.98M₹ 12.38B
Currency in INR

Gland Pharma Ltd. Earnings and Revenue History

Gland Pharma Ltd. Debt to Assets

Gland Pharma Ltd. Cash Flow

Gland Pharma Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis